The risk of recurrent venous thromboembolism is nearly 40% of all patients after 10 years of follow up. The risk is higher in patients with permanent risk factors, who should receive indefinite anticoagulation with acenocoumarol or warfarin, except cancer patients who should receive lower doses of low molecular weight heparin The remaining patients should receive a 3-month course of treatment, after which the need to continue this treatment should be reevaluated. The decision to continue should be individually tailored and balanced against hemorrhagic risk.
View Article and Find Full Text PDFWe report a case of pacemaker lead infection caused by Aspergillus fumigatus that was successfully treated by surgery and with voriconazole. This infection is rare and dangerous. When it is suspected, transesophageal echocardiography should be performed to look for lead-attached vegetations and the entire pacing system should be removed.
View Article and Find Full Text PDF